AMCN [AIRMEDIA] 6-K: (Original Filing)

[AirMedia Announces Results of 2009 Annual General Meeting Beijing, December 9, 2009 1. An amendment to the Company’s 2007 Share Incentive Plan, to increase the maximum aggregate number of shares issuable under the plan from 12 million shares to 17 million shares; 2. The adoption of an Amended and Restated Memorandum and Articles of Association, primarily for the purposes of] [AIRMEDIA GROUP INC. 2007 SHARE INCENTIVE PLAN (Amended and Restated Effective December 9, 2009) ARTICLE 1 PURPOSE Plan Company ARTICLE 2 DEFINITIONS AND CONSTRUCTION Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates. 2.1 “] [THE COMPANIES LAW (2009 REVISION) AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF AIRMEDIA GROUP INC. Adopted by a Special Resolution passed on 9 December 2009 1. AirMedia Group Inc. The name of the Company is 2. The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104,] [FORM 6-K AIRMEDIA GROUP INC. 17/F, Sky Plaza, þ Form 20-F o Form 40-F o o AIRMEDIA GROUP INC. Conor Chiahung Yang Chief Financial Officer 2 Press Release Amended and Restated Memorandum and Articles of Association 3 6-K 1 c93564e6vk.htm FORM 6-K]

By | 2016-03-23T01:35:51+00:00 December 10th, 2009|Categories: AMCN, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

HPJ [Highpower International] 8-K: (Original Filing)

[Hong Kong Highpower Technology, Inc. Announces Approval for Listing on the NASDAQ Global Market SHENZHEN, CHINA AND NEW YORK , NY, December 8 , 2009 – Hong Kong Highpower Technology, Inc. (NYSE Amex: HPJ) The company has notified the NYSE Amex that it intends to voluntarily delist its common shares from the NYSE Amex. Until the time the company begins] [(86) 755-89686238 (Former name or former address, if changed since last report.) ¨ ¨ ¨ ¨ Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or standard; Transfer of Listing. Description]

CHNR [CHINA NATURAL RESOURCES] 6-K: (Original Filing)

[Form 6-K China Natural Resources, Inc. Room 2205, 22/F, West Tower, Shun Tak Centre, 168-200 Connaught Road C., Sheung Wan, Hong Kong Effective Date of Action by Written Consent of Members The written consent in lieu of meeting of members provides that the actions taken will become effective not less than 20 days following the date that the Company’s definitive]

By | 2016-03-15T16:49:39+00:00 December 10th, 2009|Categories: Chinese Stocks, CHNR, SEC Original|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology to Address Company-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009 — Skystar Bio-Pharmaceutical Company Skystar will manufacture its aquaculture vaccine in its new 51,000]

By | 2016-03-01T06:48:31+00:00 December 9th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology todressmpany-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009ystar Bio-Pharmaceuticalmpanyystar will manufacture its aquaculture vaccine in its new 51,000 square]

By | 2016-02-05T04:45:37+00:00 December 9th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

EDS [Exceed Co] 6-K: (Original Filing)

[Exceed Company Ltd. Completes Purchase of Unit Purchase Option from Morgan Joseph & Co. Inc. ABOUT EXCEED COMPANY LTD Exceed Company Ltd. designs, develops and engages in wholesale of footwear, apparel and accessories under its own brand, XIDELONG, in China. It is one of the leading domestic sports and leisurewear brands in China in terms of market share by sales] [Description 99.1 Press Release, Dated December 8, 2009]

By | 2016-03-21T05:06:57+00:00 December 8th, 2009|Categories: Chinese Stocks, EDS, SEC Original|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] F-6: (Original Filing)

[] [TABLE OF CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al. 1 (f) Delivery Order 1 (g) Deposited Securities 2 (h) Direct Registration System 2 (i) Holder 2 (j) Securities Act of 1933 2 (k)] [December 7, 2009 JPMorgan Chase Bank, N.A., as Depositary Re: American Depositary Shares evidenced by American Depositary Receipts Dear Sirs: Based upon and subject to the foregoing, we are of the opinion that the ADSs covered by the Registration Statement, when evidenced by ADRs that are duly executed and delivered by the Depositary and issued in accordance with the terms]

Skip to toolbar